Kelly Clarkson says her weight-loss drug is "not Ozempic"

Singer and talk show host Kelly Clarkson told viewers on the May 13, 2024, episode of "The Kelly Clarkson Show" that she has lost weight with help from a prescription medication, but she pushed back on widespread speculation that it was Ozempic ^[1]. "Everybody thinks it's Ozempic. It's not," she said ^[1].

The comment came during an interview with guest Whoopi Goldberg, which opened with Clarkson complimenting Goldberg on how she looked. "It's all the weight I've lost. I've lost almost two people," Goldberg said, adding, "I am doing that wonderful shot that works for folks who need some help, and it's been really good for me" ^[1]. Goldberg has previously acknowledged taking Mounjaro, which is tirzepatide ^[1].

Clarkson, 42, then said she had lost "a lot" of weight as well. "Mine is a different one than people assume, but I ended up having to do that, too, because my bloodwork got so bad," she said ^[1]. She did not name the medication. She described it only as "something that aids in helping break down the sugar — obviously my body doesn't do it right" ^[1].

She also described being reluctant for a long time. "My doctor chased me for, like, two years, and I was like, 'No, I'm afraid of it. I already have thyroid problems,'" she said ^[1].

The numbers she gave

Clarkson said that at her heaviest she weighed 203 pounds, and that she did not fully register the change until she watched back a show she taped for her birthday at her home in New York. "All of a sudden I paused it, and I was like 'who is f--- is that?'" she recalled, adding, "You see it and you're like, 'Well, she's about to die of a heart attack'" ^[1].

She said the shift had been invisible to her and to people around her because it happened slowly. She recalled her manager, who has known her for more than 15 years, telling her, "I know, I'm kind of as shocked as you" ^[1]. Clarkson pushed back on assumptions about her mood at a higher weight: "I never saw that. I was never insecure about it. I was happy" ^[1].

The disclosure built on earlier comments. In January 2024, Clarkson said she had been diagnosed as pre-diabetic ^[1]. In a People interview that same month, she credited her weight loss to diet and activity, saying, "I dropped weight because I've been listening to my doctor — a couple years I didn't," and describing a protein-heavy diet and walking in New York City as "quite the workout" ^[1]. She did not mention medication in that January account ^[1].

Why it matters for patients

Much of what the public learns about GLP-1 drugs arrives through celebrity anecdotes, and Clarkson's is a good example of how incomplete those accounts can be. She confirmed she is on a prescription medication, ruled out one brand name, and left the rest unstated ^[1]. From these sources, it is not known which drug she takes, what dose, how long she has taken it, or whether it is a GLP-1 medicine at all.

Two details are worth noting because they reflect how these drugs are discussed. Ozempic is semaglutide, approved to treat diabetes and sometimes prescribed off-label for weight loss, which is part of why its name has become shorthand for the whole category ^[1]. And Clarkson's stated hesitancy centered on a personal medical history — thyroid problems — which she said kept her from starting for about two years despite her doctor's urging ^[1]. That kind of individual risk conversation does not translate from one person to another.

The pattern here — confirm something, deny a specific brand, decline to name the actual drug — has since shown up in other celebrity disclosures. For readers, the practical takeaway is that a public figure's partial account is not a description of what any given medication does, who it is approved for, or what it costs. Those questions are answered by prescribing information and by a clinician, not by a talk show segment.